If you or a loved one have macular degeneration, you appreciate getting important news fast. That's one thing your donations have helped the Macular Degeneration Partnership (MDP) do - and it makes a difference.
Recently, the long awaited results of the Age-Related Eye Disease Study 2 (AREDS 2) were announced and our members heard them within hours. Now that's fast!
AREDS has looked at the effect of vitamin supplementation on the progression of age-related macular degeneration (AMD). The first study, by the National Eye Institute, showed that taking this specific combination of antioxidants and zinc could slow the progression of AMD by 25%. When you are trying to hold on to every bit of vision you have left, slowing it down that much can make a big difference.
AREDS 2 (the follow-up study), looked at a modified formula that included more antioxidants and added omega-3. By sending out the word on our members could immediately make changes that might give them even better results.
The National Eye Institute recommended a different formula that could slow down the progress by an additional 20%. When MDP announced those results to our members, they called and emailed with questions that we were able to answer individually, person to person.
This is the most important thing MDP does - giving personal and caring support to everyone.
It's your contribution that allows us to provide such individual service to our seniors and their famiy members coping with vision loss. Thank you again for all you do to support Macular Degeneration Partnership in our mission.
For the full report on AREDS 2, visit our newsletter, AMD Update.